Table 2.
Different kinds of ICS inhalers.
| Type of Inhaler | Subtype | Characteristics | Advantages | Limitations | References |
|---|---|---|---|---|---|
| Nebulizers | Jet (or pneumatic) | Use compressed air or oxygen to convert liquid medication into a fine mist for inhalation. | Versatile and suitable for all ages. | Longer administration times, produce noise and vibration, require power sources, and need regular maintenance. | [76] |
| Ultrasonic | Use high-frequency vibrations to convert liquid medication into a fine mist for inhalation. | Portable and compact, have faster administration times, operate quietly. | Not suitable for medications that are heat-sensitive or contain suspensions. | [77] | |
| Mesh | Use a vibrating mesh or perforated plate to generate a fine aerosol mist from liquid medication. | Portable, lightweight, and operate silently with faster administration times. | Have limitations in delivering higher viscosity medications or large medication volumes. | [78] | |
| Dry powder inhalers (DPIs) | Single- and multi-unit doses | Deliver medication directly to the lungs in a powdered form. | Breath-activated, portable, and do not require coordination between inhalation and device activation. | Require adequate inspiratory flow for optimal drug delivery, and can be used only with specific types of dry powder medications. | [79] |
| Pressurized metered-dose inhalers (pMDIs) | Single and combined drugs | Deliver medication in a pressurized aerosol form using propellants. | Deliver a consistent dose, require minimal preparation time. | The presence of propellants and the inability to assess remaining medication levels easily. | [80] |
| Soft mist inhalers (SMIs) | None | Deliver medication as a slow-moving aerosol mist. | Provide consistent and precise dosing, generate a slow-moving mist suitable for patients with diverse inspiratory abilities, and are equipped with dose counters to monitor medication levels. | Potential clogging if not used properly, higher cost compared with other inhalers, and limited availability of medications in soft mist formulation. | [81] |